Apellis Pharmaceuticals Inc

NASDAQ: APLS
$30.37
+$1.59 (+5.5%)
Closing Price on February 5, 2025

APLS Stock Chart and Intraday Price

APLS Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 7,703.98M USD
Shares Outstanding 120,582,000
Apellis Pharmaceuticals Inc is a pioneering biopharmaceutical firm dedicated to developing innovative treatments for autoimmune and inflammatory diseases by targeting the complement system. Its flagship product, EMPAVELI, is designed for various conditions including paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy. Apellis is also advancing SYFOVRE for age-related macular degeneration and has other promising therapies in early-stage trials. Founded in 2009 and headquartered in Waltham, Massachusetts, the company collaborates with industry leaders to enhance its drug development pipeline.

APLS Articles

Prediction: This Pharma Stock Will Be the Best Performer in 2025
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Viking Therapeutics.
Trey Thoelcke
Published:

Friday's Top Analyst Upgrades and Downgrades: Allstate, Cisco, CSX, Meta Platforms, Nike, ON Semiconductor, Pinterest, SentinelOne, Zscaler and More
Friday's top analyst upgrades and downgrades included Allstate, Cisco Systems, CSX, FIGS, Meta Platforms, Nike, ON Semiconductor, Pinterest, SentinelOne and Zscaler.
Lee Jackson
Published:

Wednesday Afternoon's Analyst Upgrades and Downgrades: AeroVironment, AutoZone, BigCommerce, NXP Semiconductors, Roblox, Stitch Fix and More
Wednesday afternoon's top analyst upgrades and downgrades included AeroVironment, AutoZone, BigCommerce, NXP Semiconductors, Roblox, Stitch Fix and more.
Chris Lange
Published:

Friday's Top Analyst Upgrades and Downgrades: American Tower, Best Buy, Beyond Meat, Freeport McMoRan, First Solar, UnitedHealth and More
Friday’s top analyst upgrades and downgrades included American Tower, Best Buy, Beyond Meat, Editas Medicine, Freeport McMoRan, First Solar and UnitedHealth.
Chris Lange
Published:

Thursday Afternoon Analyst Upgrades and Downgrades: Apple, AutoDesk and More
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Thursday, including Apple, AutoDesk, Beazer Homes and New Fortress Energy.
Chris Lange
Published:

Amicus, Bloomin' Brands, Seagate and More Friday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Amicus Therapeutics, Bloomin' Brands, Children’s Place and Seagate Technology.
Chris Lange
Published:

Amazon, Chipotle, Disney and More Friday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Amazon, Bloom Energy, Chipotle and Disney.
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: Accenture, AB InBev, Cerner, CNOOC, Delta, Ford, GoDaddy, Kinder Morgan, Newmont, NuStar, United, Visa and More
Wednesday's top analyst upgrades, downgrades and initiations included Accenture, Anheuser-Busch InBev, Cerner, CNOOC, Delta Air Lines, Ford, GoDaddy, Kinder Morgan, Newmont, NuStar, United Airlines...
Jon C. Ogg
Published:
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.